A2L
The Alps seen from Sainte-Croix, above the sea of fog

From technology to market · Based in Switzerland, active internationally

Building the company around a technology, to turn it into real Innovation.

For 15 years, A2L has been the vehicle through which I take executive roles in technology companies: on the executive team or as CEO, from early-stage ventures to established industrial operations.

The journey

A technology becomes an Innovation only once it reaches the market, or is implemented in operations.

Until then, it remains a promise. From an idea to a product a customer pays for, there are several valleys of death to cross. Each one calls for a different discipline, and speed is won or lost at the handovers.

Bringing an invention to the market means building the company around it: the industrial capability, the organisation, the protection and the business model.

This kind of construction impacts the shape of the organisation itself, which makes it a task for executive management.

How I work

A multilateral win-win ecosystem.

A large group deals with each supplier one by one and imposes its terms. An SME or a start-up cannot: it has to give every party around it, from suppliers to investors, a reason to want it to succeed. That is how I create value: through lasting partnerships rather than one-off transactions.

This way of working is a tradition where I live: in the heart of the Jura watchmaking arc, companies have always worked as an ecosystem of specialists, each bringing its part to a very complex product.

As an executive, I decide, but I build the decisions with the people they depend on.

I can hold this role full-time or fractionally: what changes is the cadence, not the commitment to the result. In several cases, I am also a shareholder.

Examples of mandates

Micro-fluidics, marine infrastructure, blood sampling, deep geothermal energy, drug delivery.

PreciflexChief Innovation Officer · 2017-2026
Micro-fluidics

Member of the executive team. The patent portfolio generates licensing revenue, and 3 spin-offs were created on IP transfers he elaborated.

SeaNestChief Executive Officer · 2021-2026
Marine infrastructure · Climate adaptation

Co-inventor of the founding patents. From a miniature model to a full-size prototype on Lake Neuchâtel, with the business model, the financing and the Canadian market behind it.

PreciHealthChief Innovation Officer · since 2017
Medtech

On the executive team from day one, in support of medical devices that democratise blood sampling and self-injection.

EAPOSYSIntellectual property & industrialisation · since 2018
Energy · Deeptech

Core-team member of a Swiss deep-geothermal venture, alongside the founders, the board and the technical advisors.

PLM MedicalCo-founder · since 2021
Drug delivery · Medtech

A venture project of his own, to remove the manual handling still required to reconstitute lyophilised drugs, a source of contamination risk and dosing errors.

Further mandates of the same nature are carried out under confidentiality agreements.

Biography

Alain Jaccard

Alain Jaccard

Founder, CEO

Alain Jaccard builds companies around technologies that work but are not yet ready to scale. 30 years in Swiss export industry, 14 at C-level, in microtechnology, industrial automation, automotive, watchmaking, medical devices, consumer appliances at mass scale, and marine infrastructure. Operations and partners across Europe, Asia, Africa and North America.

ETEL, 1995. The company sold only custom-made motors, and decided to add a standard product line. As the only German speaker, at 23, he was put in charge of the German market. He developed the motor ranges, optimised for the available production equipment, and set the pricing policy. He personally explained direct drives to R&D managers in German across the whole country and managed the sales process. Within 2 years, standard motors were ETEL's largest business stream and Germany its largest market. He was called back twice: in 1999 to train the worldwide sales force, and in 2003 to design "Concevoir", the development process that halved project duration and is still in use today.

MEDAIR, 1998-2001. Twice in that period he left industry: 2.5 years of emergency humanitarian operations in conflict zones (Sudan, Albania, DR Congo), leading 200 people across 3 sites at the age of 27.

Sonceboz, 2002-2003. He delivered the company's first 2 fully automated assembly lines for automotive instrumentation, an investment of more than CHF 3.5 mio. He took over part of the supplier's project management when that supplier nearly went bankrupt and was acquired mid-project.

Nespresso, 2007 to 2011. The company had been growing 30% a year for more than 10 years, and the established development network could not keep up. He set up an additional development capability, including a test lab, with a new partner in Lyon and a direct link to the OEM in China. It was operational within 6 months. He was then promoted to Technology Innovation Manager, although his peers and his own manager had been with the company longer: 8 to 11 people, CHF 12 mio a year, and a seat on the IP Decision Committee.

Preciflex, 2012. He was hired as first employee while the company was only a postal address with external partners. Its client HYT had taken pre-orders for a watch whose 2 prototypes were barely functional. Within 6 weeks, he proposed to bring the key processes in-house, and the Board accepted. Less than 6 months later, HYT was able to deliver its first 28 watches. After 12 months, the production and industrialisation departments were set up (13 employees), with a capacity of 1,000 modules per year. 5 patent families protected the know-how built through industrialisation. As Chief Innovation Officer from 2017, member of the executive team, he took over innovation and intellectual property: the portfolio generates licensing revenue, and even the largest players in luxury and watchmaking come to the company for technology developments. He led the IP committee that brought together the Chairman of the Board and the executive team. 3 spin-offs (PreciHealth, Hulecos, Combi-DX) were created on IP transfers he elaborated.

SeaNest, 2021 to 2026, as co-inventor of the founding patents and Chief Executive Officer. He took the company from a miniature model to a real-life prototype, launched on Lake Neuchâtel and presented publicly before the cantonal authorities, with regional media coverage. The prototype withstood winds of 140 km/h without damage. With the Board, he built the business model on the IP itself: bidirectional licensing with construction consortia. He obtained financing through capital increases, convertible loans and public grants. Through 2 economic missions of the Canton of Neuchâtel, he qualified Canada as a market as well as an industrialisation location, and built the partner network there.

Since 2011, he has run his own company, A2L, full-time since 2020, through which he holds executive roles, as CEO or member of the executive team, with 5 to 10 parallel mandates, and in some cases also as shareholder.

MSc EPFL in microengineering, PMP, Harvard Business School Certificate of Management Excellence, Startup Board Academy. Named inventor in 46+ published patent families. Swiss citizen, works in French, English and German.

Contact

Tell me about your project.